BD Reveals Commercial Launch Of New Robotics Solution That Will Enable Automation
Portfolio Pulse from Benzinga Newsdesk
BD has launched a new robotics solution in collaboration with Hamilton, aimed at automating and standardizing processes for genetic sequencing. The solution includes the BD® OMICS-One XT WTA Assay and the Hamilton Microlab NGS STAR platform, facilitating easier integration into existing workflows.
October 14, 2024 | 10:48 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
BD has introduced a new robotics solution in partnership with Hamilton, which automates and standardizes genetic sequencing processes. This could enhance BD's market position in genomics by integrating with existing lab workflows.
The launch of the new robotics solution is likely to positively impact BD's stock in the short term as it enhances their product offerings in the genomics field. The integration with existing Hamilton platforms could lead to increased adoption and sales.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80